- Corporate Officers - B
- Butitta Cynthia M
Insider Trading History of Butitta Cynthia M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Butitta Cynthia M since 2006.
The trader's CIK number is 1222082.
At the time of the last reporting, Butitta Cynthia M was the Director of Olema Pharmaceuticals, Inc.. (stock ticker symbol OLMA).
Also see all insider trading activities at Olema Pharmaceuticals, Inc..
Note that in the past
BUTITTA CYNTHIA M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Olema Pharmaceuticals, Inc. (OLMA) by Butitta Cynthia M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | OLMA | 0 | $0 | 0 | $0 | 83,876 | $369,557 |
Yearly summary of insider trading at Mabvax Therapeutics Holdings, Inc. (TELK) by Butitta Cynthia M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | TELK | 5,000 | $77,350 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kite Pharma, Inc. (KITE) by Butitta Cynthia M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | KITE | 0 | $0 | 159,228 | $13,494,261 | 150,000 | $202,499 |
2016 | KITE | 0 | $0 | 102,482 | $5,311,089 | 100,000 | $135,000 |
2015 | KITE | 0 | $0 | 100,000 | $6,504,045 | 90,000 | $121,500 |
Insider trading activities at 3 companies by Butitta Cynthia M:
1. Olema Pharmaceuticals, Inc. (OLMA)
2. Mabvax Therapeutics Holdings, Inc. (TELK)
3. Kite Pharma, Inc. (KITE)
Table 1. Insider trading of Olema Pharmaceuticals, Inc. (OLMA) by Butitta Cynthia M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-09-16 | OLMA | Option Ex | 83,876 | 4.41 | 369,557 |
Table 2. Insider trading of Mabvax Therapeutics Holdings, Inc. (TELK) by Butitta Cynthia M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-08-10 | TELK | Buy | 5,000 | 15.47 | 77,350 |
Table 3. Insider trading of Kite Pharma, Inc. (KITE) by Butitta Cynthia M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-09-25 | KITE | Sale | 4,228 | 179.66 | 759,619 |
2017-08-10 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
2017-08-10 | KITE | Sale | 15,000 | 120.78 | 1,811,625 |
2017-07-10 | KITE | Sale | 15,000 | 102.89 | 1,543,350 |
2017-07-10 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
2017-06-23 | KITE | Sale | 5,000 | 100.86 | 504,325 |
2017-06-09 | KITE | Sale | 10,000 | 88.16 | 881,600 |
2017-06-09 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2017-04-25 | KITE | Sale | 15,000 | 81.97 | 1,229,505 |
2017-04-25 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
2017-04-03 | KITE | Sale | 5,000 | 82.69 | 413,440 |
2017-04-03 | KITE | Option Ex | 5,000 | 1.35 | 6,750 |
2017-03-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2017-03-27 | KITE | Sale | 10,000 | 77.45 | 774,550 |
2017-03-09 | KITE | Option Ex | 21,118 | 1.35 | 28,509 |
2017-03-09 | KITE | Sale | 21,118 | 80.83 | 1,707,073 |
2017-03-01 | KITE | Sale | 28,882 | 80.05 | 2,312,004 |
2017-02-27 | KITE | Sale | 10,000 | 55.03 | 550,320 |
2017-03-01 | KITE | Option Ex | 28,882 | 1.35 | 38,990 |
2017-02-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2017-01-31 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2017-01-31 | KITE | Sale | 10,000 | 50.56 | 505,560 |
2017-01-06 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2017-01-06 | KITE | Sale | 10,000 | 50.13 | 501,290 |
2016-12-20 | KITE | Sale | 2,482 | 50.86 | 126,234 |
2016-11-25 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-11-25 | KITE | Sale | 10,000 | 50.90 | 508,950 |
2016-11-10 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-11-10 | KITE | Sale | 10,000 | 50.95 | 509,450 |
2016-09-26 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-09-26 | KITE | Sale | 10,000 | 54.13 | 541,300 |
2016-08-25 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-08-25 | KITE | Sale | 10,000 | 58.52 | 585,250 |
2016-07-25 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-07-25 | KITE | Sale | 10,000 | 50.94 | 509,350 |
2016-06-23 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-06-23 | KITE | Sale | 10,000 | 51.27 | 512,750 |
2016-06-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-06-27 | KITE | Sale | 10,000 | 50.15 | 501,480 |
2016-04-04 | KITE | Sale | 10,000 | 50.00 | 500,000 |
2016-04-04 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-03-01 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2016-03-01 | KITE | Sale | 10,000 | 50.03 | 500,300 |
2016-02-02 | KITE | Option Ex | 1,900 | 1.35 | 2,565 |
2016-02-02 | KITE | Sale | 1,900 | 50.13 | 95,247 |
2016-01-27 | KITE | Sale | 8,100 | 51.95 | 420,778 |
2016-01-27 | KITE | Option Ex | 8,100 | 1.35 | 10,935 |
2015-12-28 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2015-12-28 | KITE | Sale | 10,000 | 61.70 | 616,950 |
2015-11-27 | KITE | Sale | 15,000 | 86.62 | 1,299,375 |
2015-11-27 | KITE | Option Ex | 15,000 | 1.35 | 20,250 |
2015-11-10 | KITE | Option Ex | 5,000 | 1.35 | 6,750 |
2015-11-10 | KITE | Sale | 5,000 | 80.00 | 400,000 |
2015-10-27 | KITE | Sale | 10,000 | 70.26 | 702,570 |
2015-10-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2015-09-28 | KITE | Sale | 10,000 | 55.78 | 557,800 |
2015-09-28 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2015-08-27 | KITE | Sale | 10,000 | 53.60 | 536,000 |
2015-08-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2015-07-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2015-07-27 | KITE | Sale | 10,000 | 68.55 | 685,450 |
2015-06-29 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2015-06-29 | KITE | Sale | 10,000 | 59.88 | 598,770 |
2015-05-27 | KITE | Option Ex | 10,000 | 1.35 | 13,500 |
2015-05-27 | KITE | Sale | 10,000 | 50.95 | 509,510 |
2015-04-27 | KITE | Sale | 10,000 | 59.76 | 597,620 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Butitta Cynthia M
(Director of Olema Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.